S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.04%) $0.927
USD/NOK
(0.31%) $10.87
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.31%) $92.29

Realtime updates for China Medical System [0867.HK]

Exchange: HKSE Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated28 Mar 2024 @ 04:08

-34.45% HKD 8.22

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 04:08):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China...

Stats
Today's Volume 49.73M
Average Volume 3.55M
Market Cap 20.16B
EPS HKD0 ( 2024-03-26 )
Last Dividend HKD0.342 ( 2023-09-11 )
Next Dividend HKD0 ( N/A )
P/E 7.75
ATR14 HKD0.0230 (0.28%)

Volume Correlation

Long: -0.23 (neutral)
Short: -0.19 (neutral)
Signal:(31.181) Neutral

China Medical System Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

China Medical System Correlation - Currency/Commodity

The country flag 0.19
( neutral )
The country flag -0.14
( neutral )
The country flag 0.00
( neutral )
The country flag 0.19
( neutral )
The country flag -0.32
( neutral )
The country flag 0.33
( neutral )

China Medical System Financials

Annual 2022
Revenue: HKD9.15B
Gross Profit: HKD7.04B (76.89 %)
EPS: HKD1.330
Q2 2023
Revenue: HKD2.31B
Gross Profit: HKD1.80B (78.22 %)
EPS: HKD0.390
Q1 2023
Revenue: HKD2.31B
Gross Profit: HKD1.80B (78.22 %)
EPS: HKD0.390
Q4 2022
Revenue: HKD2.35B
Gross Profit: HKD1.80B (76.55 %)
EPS: HKD0.300

Financial Reports:

No articles found.

China Medical System Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
HKD0.337
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0.274
(N/A)
HKD0.342
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)
HKD0
(N/A)

China Medical System Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 5.93 - Stable (18.64%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend HKD0.00693 2011-03-22
Last Dividend HKD0.342 2023-09-11
Next Dividend HKD0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 26 --
Total Paid Out HKD3.99 --
Avg. Dividend % Per Year 0.00% --
Score 3.82 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 5.93
Div. Directional Score 8.54 --
Next Divdend (Est)
(2024-07-05)
HKD0.359 Estimate 12.50 %
Dividend Stability
0.50 Average
Dividend Score
3.82
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Warning: Undefined variable $stockPricesArray in /home/getagraph/public_html/stock.php on line 1111

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
6993.HK Ex Dividend Knight 2023-06-20 Annually 0 0.00%
2003.HK Ex Dividend Knight 2023-10-17 Annually 0 0.00%
1084.HK Ex Dividend Junior 2023-06-06 Semi-Annually 0 0.00%
0168.HK Ex Dividend Knight 2023-06-21 Annually 0 0.00%
3658.HK Ex Dividend Knight 2023-09-28 Annually 0 0.00%
1651.HK Ex Dividend Knight 2023-08-22 Semi-Annually 0 0.00%
0709.HK Ex Dividend Knight 2023-09-05 Semi-Annually 0 0.00%
9983.HK Ex Dividend Junior 2023-09-18 Semi-Annually 0 0.00%
2199.HK Ex Dividend Knight 2023-09-18 Annually 0 0.00%
1223.HK No Dividend Player 2023-06-27 Sporadic 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.3631.5002.744.11[0 - 0.5]
returnOnAssetsTTM0.1841.2003.874.64[0 - 0.3]
returnOnEquityTTM0.2211.5008.6510.00[0.1 - 1]
payoutRatioTTM0.388-1.0006.12-6.12[0 - 1]
currentRatioTTM4.160.80010.008.00[1 - 3]
quickRatioTTM3.690.80010.008.00[0.8 - 2.5]
cashRatioTTM2.011.50010.0010.00[0.2 - 2]
debtRatioTTM0.0719-1.5008.80-10.00[0 - 0.6]
interestCoverageTTM01.000-1.111-1.111[3 - 30]
operatingCashFlowPerShareTTM1.4652.009.5110.00[0 - 30]
freeCashFlowPerShareTTM1.4572.009.2710.00[0 - 20]
debtEquityRatioTTM0.0827-1.5009.67-10.00[0 - 2.5]
grossProfitMarginTTM0.7741.0000.4380.438[0.2 - 0.8]
operatingProfitMarginTTM0.3871.0004.264.26[0.1 - 0.6]
cashFlowToDebtRatioTTM2.721.00010.0010.00[0.2 - 2]
assetTurnoverTTM0.5070.8009.967.97[0.5 - 2]
Total Score11.14

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM5.501.0009.550[1 - 100]
returnOnEquityTTM0.2212.509.1310.00[0.1 - 1.5]
freeCashFlowPerShareTTM1.4572.009.5110.00[0 - 30]
dividendYielPercentageTTM8.121.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM1.4652.009.5110.00[0 - 30]
payoutRatioTTM0.3881.5006.12-6.12[0 - 1]
pegRatioTTM0.2731.500-1.5120[0.5 - 2]
operatingCashFlowSalesRatioTTM0.3861.0002.860[0.1 - 0.5]
Total Score5.93

China Medical System

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People's Republic of China. The company's products include Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu for the treatment of acute heart failure; Deanxit for the treating mild-to-moderate depression, anxiety, and psychosomatic affections; Ursofalk for the treatment of cholesterol gallstones in the gallbladder, cholestatic liver disease, and biliary reflux gastritis; Salofalk for treating Ulcerative Colitis and Crohn's disease; Bioflor for the treatment of diarrhea; Combizym for dyspepsia; Augentropfen Stulln Mono eye drops to treat senile macula degeneration and asthenopia; and Hirudoid for blunt traumata with or without hematomas and superficial phlebitis insofar. Its products also comprise DanShenTong capsules for treating acne, tonsillitis, otitis externa, boils, carbuncle, traumatic infection, burn infection, mastitis, cellulitis, osteomyelitis, etc.; XiDaKang, a protein hydrolysate oral solution; YiNuoShu for treating respiratory diseases; Ganfule capsules for the treatment of primary cancer of the liver; Imdur for the treatment of coronary heart disease, chronic heart failure, and myocardial infarction, as well as for prevention of vasospasm and mixed angina; and Parlodel tablets for the endocrine and neuro system indications. In addition, the company also offers Elcatonin injection for osteoporosis; YinlianQinggan granules for treating acute hepatitis A and chronic hepatitis B; Lamisil tablets for treating fungal infections on skin and hair; and MOVICOL for treating chronic constipation and faecal impaction. In addition, it is involved in the agriculture and livestock activities. The company was founded in 1995 and is headquartered in North Point, Hong Kong. China Medical System Holdings Limited is a subsidiary of Treasure Sea Limited.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators